bromodeoxyuridine has been researched along with Gangliocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, S; Beleta, H; de Torres, C; Díaz, R; García, I; Lavarino, C; Mora, J; Rodríguez, E; Suñol, M; Toran, N | 1 |
| Clark, GJ; Ekström, TJ; Farnebo, F; Geli, J; Juhlin, C; Kiss, N; Kogner, P; Lanner, F; Larsson, C; Natalishvili, N | 1 |
2 other study(ies) available for bromodeoxyuridine and Gangliocytoma
| Article | Year |
|---|---|
The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
Topics: Bromodeoxyuridine; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Ganglioneuroblastoma; Ganglioneuroma; Humans; Neuroblastoma; Neuroglia; Neurons; Parathyroid Hormone-Related Protein; Receptors, Calcium-Sensing; RNA, Messenger; Schwann Cells; Tretinoin; Up-Regulation | 2009 |
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Bromodeoxyuridine; Cell Line, Tumor; DNA Methylation; Down-Regulation; Ganglioneuroma; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Hydroxamic Acids; Monomeric GTP-Binding Proteins; Neuroblastoma; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |